about
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAsExpression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changesCharacterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationElimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancerStromal elements act to restrain, rather than support, pancreatic ductal adenocarcinomaA novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor controlTargeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions.Human cancer growth and therapy in immunodeficient mouse models.The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic AnalysisTherapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinomaThree-dimensional culture and interaction of cancer cells and dendritic cells in an electrospun nano-submicron hybrid fibrous scaffold.Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.The enigmatic cytokine oncostatin m and roles in diseaseSpleen cells from young but not old immunized mice eradicate large established cancers.Stromal cell induction of regulatory dendritic cells.Deciphering and reversing tumor immune suppression.Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients.Polyethylene sebacate doxorubicin nanoparticles: role of carbohydrate anchoring on in vitro and in vivo anticancer efficacy.Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions.EBV oncogene N-LMP1 induces CD4 T cell-mediated angiogenic blockade in the murine tumor model.RAS interaction with PI3K p110α is required for tumor-induced angiogenesis.Targeting high-grade B cell lymphoma with CD19-specific T cells.Immunotherapy of cancers comes of age.Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion.Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.In silico modeling of cancer cell dissemination and metastasis.Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?Engineering chimeric antigen receptor-T cells for cancer treatment.Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.
P2860
Q27334649-89618E3B-18A4-498E-9ECD-322F468BF38AQ28292423-5722AE69-A5C7-4FB0-93EA-DF07FBF24C7DQ28552410-296C5ED4-8D7F-4D7D-B516-5CDAD0F98AAFQ33587034-96438D3F-16B4-46EF-B76F-287E63294B0EQ33877484-41690D8D-AE04-44EE-8722-A6CD83D37F79Q33896442-B8CAA89C-16D3-4D7A-865A-F9C13F3EE44FQ34670378-D4425C6D-95C6-4097-BDFE-0E40BAE01C36Q35537413-212559A3-243D-4205-96DF-1D704E3CC86FQ35543172-0B17FDA3-5C2F-4B91-B44E-4D5815DFEC89Q35545282-BDBC3D84-4153-4165-B63C-1FAAD18DB48EQ35611945-D012F4B2-B3C0-4113-8FDF-21F03F0806CEQ36128151-76CB413A-ABDB-465B-8434-88E15E988A5AQ36545163-45AC4AFD-56B2-41E1-A1EE-82113C8E6366Q36659337-798CA201-7A34-4C6C-9470-E85401362494Q37203714-54268B5D-418E-46B6-99DC-4F1C4D17109AQ37409222-C7717DF3-7184-4DC0-AC7F-CA8CDD8EF7C8Q37706396-984CE357-841D-4C13-B814-B2EE83A7F4EEQ38039093-DDC42F4B-B350-44C1-95DC-00B668D4D578Q38124437-026F4222-FA62-42A0-9C49-127A28296E07Q38420937-CA428463-0D54-470F-A7FC-AF8CA320D473Q38801585-DA0ECE46-21FB-418E-80D4-69CC3736BC3BQ38841939-1CB2945F-4193-44F4-9281-1BA9B7DCCDA4Q38890228-42A96174-B343-4488-88D9-4591C61B2296Q38977239-0667D918-DD97-48FC-841C-C817FAAEFB46Q39026731-5197EE0C-4EF8-42DD-B6FB-488079FB7CC8Q40099075-3ADDBA13-0E5E-4CB7-BCF1-262945CB2F0FQ41261844-EE3F342B-0261-45CC-9488-FC4B8441C4B4Q42183460-86329205-52AC-4DF1-B675-2B867A5B5045Q42194464-0A6BA05C-D78E-405F-8387-A7D4675197ABQ42573824-25C42B50-AD8E-4C04-A198-7DD467EDF3CDQ46868336-7C792856-0BF4-4E6C-A05A-5034D36AD675Q48219198-06DD8E96-191B-4EF6-90F4-183BCAB8BF92Q49962991-72742E2B-F5C4-40D4-8B58-2037F8D331BFQ52641846-D6F0490D-12AC-4EB9-BC7B-EC9D37DE782DQ55018323-6E74F9FF-2C0D-44BF-A08F-630990625677
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting stroma to treat cancers.
@en
Targeting stroma to treat cancers.
@nl
type
label
Targeting stroma to treat cancers.
@en
Targeting stroma to treat cancers.
@nl
prefLabel
Targeting stroma to treat cancers.
@en
Targeting stroma to treat cancers.
@nl
P2093
P2860
P1476
Targeting stroma to treat cancers.
@en
P2093
Boris Engels
Donald A Rowley
Hans Schreiber
P2860
P356
10.1016/J.SEMCANCER.2011.12.008
P577
2011-12-24T00:00:00Z